These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9696398)

  • 41. MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors.
    González-Vela MC; Garijo MF; Fernández F; Val-Bernal JF
    Histol Histopathol; 2001 Apr; 16(2):399-406. PubMed ID: 11332695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis.
    Rudas M; Gnant MF; Mittlböck M; Neumayer R; Kummer A; Jakesz R; Reiner G; Reiner A
    Breast Cancer Res Treat; 1994; 32(2):165-75. PubMed ID: 7865846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bromodeoxyuridine labeling for S-phase measurement in breast carcinoma.
    Meyer JS; Koehm SL; Hughes JM; Higa E; Wittliff JL; Lagos JA; Manes JL
    Cancer; 1993 Jun; 71(11):3531-40. PubMed ID: 8490901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
    Markiewski M; Domagała W
    Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
    Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
    Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer.
    Lynch BJ; Guinee DG; Holden JA
    Hum Pathol; 1997 Oct; 28(10):1180-8. PubMed ID: 9343325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
    Abry E; Thomassen IØ; Salvesen ØO; Torp SH
    Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer.
    Brown RW; Allred CD; Clark GM; Osborne CK; Hilsenbeck SG
    Clin Cancer Res; 1996 Mar; 2(3):585-92. PubMed ID: 9816207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index.
    Mori N; Ota H; Mugikura S; Takasawa C; Ishida T; Watanabe G; Tada H; Watanabe M; Takase K; Takahashi S
    Radiology; 2015 Jan; 274(1):66-73. PubMed ID: 25203132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormonal factors and breast tumor proliferation: do factors that affect cancer risk also affect tumor growth?
    Oestreicher N; White E; Malone KE; Porter PL
    Breast Cancer Res Treat; 2004 May; 85(2):133-42. PubMed ID: 15111771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between iododeoxyuridine and MIB-1 labelling index in gastric carcinoma and adjacent normal gastric tissue.
    Schipper DL; Wagenmans MJ; Peters WH; Wobbes T; Wagener DJ
    Anticancer Res; 2000; 20(2A):707-14. PubMed ID: 10810344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BGX-Ki-67 index as a supplementary marker to MIB-1 index, enabling more precise distinction between luminal A and B subtypes of breast carcinoma and eliminating the problem of membranous/cytoplasmic MIB-1 staining.
    Niemiec J; Adamczyk A; Ambicka A; Mucha-Małecka A; Wysocki WM; Majchrzyk K; Ryś J
    Am J Clin Pathol; 2015 Mar; 143(3):419-29. PubMed ID: 25696801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study of two complementary proliferation markers in 200 breast carcinomas: Ki67 and mitotic index.
    El Amine O; Ouni R; Adouni O; Goucha A; Ben Hassouna J; Rahal K; El May A; Gamoudi A
    Tunis Med; 2016 Oct; 94(10):587-593. PubMed ID: 28972249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer.
    Aziz S; Wik E; Knutsvik G; Klingen TA; Chen Y; Davidsen B; Aas H; Aas T; Akslen LA
    PLoS One; 2016; 11(3):e0150979. PubMed ID: 26954367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis.
    Sahin AA; Ro J; Ro JY; Blick MB; el-Naggar AK; Ordonez NG; Fritsche HA; Smith TL; Hortobagyi GN; Ayala AG
    Cancer; 1991 Aug; 68(3):549-57. PubMed ID: 1648433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An intra- and interobserver reproducibility analysis of the Ki-67 proliferation marker assessment on core biopsies of breast cancer patients and its potential clinical implications.
    Vörös A; Csörgő E; Nyári T; Cserni G
    Pathobiology; 2013; 80(3):111-8. PubMed ID: 23258384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison between different cell kinetic variables in human breast cancer.
    Barzanti F; Dal Susino M; Volpi A; Amadori D; Riccobon A; Scarpi E; Medri L; Bernardi L; Naldi S; Aldi M; Gaudio M; Zoli W
    Cell Prolif; 2000 Apr; 33(2):75-89. PubMed ID: 10845252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis.
    Mehdi MZ; Nagi AH; Naseem N
    Int Braz J Urol; 2016; 42(6):1121-1128. PubMed ID: 27532114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
    Wu YF; Xu HM; Chen JQ
    Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic values of proliferative markers ki-67 and repp86 in breast cancer.
    Mohsenifar J; Almassi-Aghdam M; Mohammad-Taheri Z; Zare K; Jafari B; Atri M; Mortazavi SH; Azadeh P; Bagherzadeh M; Azargashb E; Rahimi F
    Arch Iran Med; 2007 Jan; 10(1):27-31. PubMed ID: 17198450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.